 International Collaboration on Medical Device Regulation: Issues, Problems and StakeholdersChrista Altenstetter Chapter 11 in Commercialization of Health Care, 2005, pp 170-186 from Palgrave Macmillan Abstract: Abstract Commercialization of health care around the globe manifests itself in the liberalization of markets and global trade and health care reform measures, including competition and privatization, generating a shift in the balance of power away from the stewardship of the state to free markets. These transformations are especially important for medical devices which carry special risks when unregulated or inappropriately regulated. They may be wrongly classified, dumped on foreign markets where regulatory requirements may be lower, or can even be fraudulent products. The key issue for public health is whether recent trade in medical products, as well as the global and regional harmonization of product and diagnostic standards, have encouraged a widening gap between patients and providers. Conversely, has commercialization produced some tangible (if indirect) benefits to some patient groups and providers? Keywords: Medical Device; International Collaboration; Intellectual Property Right; Trip Agreement; National Electrical Manufacturer Association (search for similar items in EconPapers) There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:pal:sopchp:978-0-230-52361-6_11 Ordering information: This item can be ordered from Access Statistics for this chapter More chapters in Social Policy in a Development Context from Palgrave Macmillan |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.